• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Sweden·Healthcare·STIL.ST
Share

Stille AB Stocks

SEK 265.5Last Updated 12.06.2026

Issuer Rating

4/7
Performance

Average

Risk

Moderate

Recommendation

Hold

Market Cap

SEK 251.18M

SEK 265.5
Key Takeaways

Risk factor

Poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Stille AB is a Swedish-headquartered company, operating globally, that specializes in the design, manufacture, and sale of surgical instruments. Their extensive portfolio of medical tools encompasses a wide variety of items such as specialized forceps (including artery, ligature, wire twisting, and general types), bone-cutting instruments like cutters and rongeurs, various clamps, curettes, raspatories, elevators, needle holders, micro instruments, osteotomes, chisels, retractors, skin hooks, and scissors. Additionally, they provide C-arm tables. These products are essential for a broad range of surgical disciplines, including ERCP/abdominal fluoroscopy, neuro/spine, pain management, urology, and vascular surgeries, as well as general open surgical procedures. Beyond product provision, Stille also offers crucial post-sales support services, such as instrument repair, routine maintenance, and thorough inspections. The company leverages strategic partnerships, notably a collaboration agreement with GE Healthcare and a distribution arrangement with Synovis Micro. Its sales strategy involves direct customer engagement, distribution networks, and supply to OEM manufacturers of C-frame systems. Founded in 1841 and headquartered in Torshälla, Sweden, Stille AB operates as a subsidiary of Linc AB.

Company Valuation

Overvalued
2/7

Based on key historical and expected multiples, the stock is overvalued relative to its peers. In particular, the stock is reasonably priced on P/E, 'expensive' on EV/EBI

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of STIL.ST is 285 and suggests 8% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

13.06.2026 03:02

Microsoft is considering spinning off Xbox into a separate company - The Information

13.06.2026 01:40

Hope for peace with Iran and SpaceX lifted spirits: stocks rose for second straight day

13.06.2026 01:05

SpaceX shares rose in value by 19% on the first day of trading. Is it worth buying them?

13.06.2026 01:04

SpaceX shares slowed before closing in first trading since record IPO

13.06.2026 00:44

Retail investors bought $15 billion worth of SpaceX stock. Demand was at least 6 times that amount

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026